Effect of Intravitreous Rituximab Injections in Patients With Recurrent Ocular Lesions Associated With Central Nervous System Lymphoma

Archives of Ophthalmology
doi 10.1001/archopht.126.7.1002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Treatment of Central Nervous System Lymphoma in Rats With Intraventricular Rituximab and Serum

International Journal of Hematology
Hematology
2010English

Rituximab Monotherapy for Patients With Recurrent Primary CNS Lymphoma

Neurology
Neurology
2011English

Correction To: White Matter Changes in Primary Central Nervous System Lymphoma Patients Treated With High-Dose Methotrexate With or Without Rituximab

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2019English

Frequency, Risk Factors, and Outcomes of Central Nervous System Relapse in Lymphoma Patients Treated With Dose-Adjusted EPOCH Plus Rituximab

American Journal of Hematology
Hematology
2017English

Electrophoretic Analysis of Cerebrospinal Fluid Proteins in Patients With Central Nervous System Mass Lesions

Journal of Neurosurgery
SurgeryNeurology
1972English

Primary Central Nervous System Lymphoma With Lateral Ventricle Involvement

The Open Medical Imaging Journal
2012English

A Prospective Study on the Circulation and Central Nervous System Afterprimary Central Nervous System B Cell Lymphomatreatment With Rituximab

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

A Phase I Trial of Lenalidomide in Patients With Recurrent Primary Central Nervous System Tumors

Clinical Cancer Research
Cancer ResearchOncology
2007English

Primary Central Nervous System Lymphoma

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy